|
Gomez I, Egui A, Palacios G, Carrilero B, Benitez C, Simon M, Segovia M, Carmelo E, Lopez MC, Thomas MC. The expression of immune response genes in patients with chronic Chagas disease is shifted toward the levels observed in healthy subjects as a result of treatment with Benznidazole. Front Cell Infect Microbiol. 2024 Jul 23;14:1439714. doi: 10.3389/fcimb.2024.1439714. eCollection 2024. PubMed PMID: 39119291; PubMed Central PMCID: PMC11307780.
AÑO: 2024; IF: 4.6
|
39119291
|
Vazquez C, Garcia-Vazquez E, Carrilero B, Simon M, Franco F, Iborra MA, Gil-Gallardo LJ, Segovia M. Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole. Rev Soc Bras Med Trop. 2023 Jan 23;56:e0384-2022. doi: 10.1590/0037-8682-0384-2022. eCollection 2023. PubMed PMID: 36700605; PubMed Central PMCID: PMC9870279.
AÑO: 2023; IF: 1.8
|
|
Simon M, Ladron de Guevara P, Polo SA, Sierra S, Segovia M. The community pharmacy as a strategic ally in the fight against Chagas disease. Travel Med Infect Dis. 2023 Mar-Apr;52:102527. doi: 10.1016/j.tmaid.2022.102527. Epub 2022 Dec 17. No abstract available. PubMed PMID: 36539020.
AÑO: 2023; IF: 6.3
|
|
Gomez I, Lopez MC, Egui A, Palacios G, Carrilero B, Benitez C, Simon M, Segovia M, Carmelo E, Thomas MC. Differential expression profile of genes involved in the immune response associated to progression of chronic Chagas disease. PLoS Negl Trop Dis. 2023 Jul 13;17(7):e0011474. doi: 10.1371/journal.pntd.0011474. eCollection 2023 Jul. PubMed PMID: 37440604; PubMed Central PMCID: PMC10368263.
AÑO: 2023; IF: 3.4
|
|
Gil-Gallardo L, Simon M, Iborra A, Carrilero B, Segovia M. Chemiluminescent Microparticle Immunoassay for the Diagnosis of Congenital Chagas Disease: A Prospective Study in Spain. Am J Trop Med Hyg. 2021 Oct 4;105(6):1701-1705. doi: 10.4269/ajtmh.21-0332. PubMed PMID: 34607304; PubMed Central PMCID: PMC8641311.
AÑO: 2021; IF: 3.707
|